Day: January 9, 2026

FDA Clarifies Regulation for AI Health Devices

The FDA announced that consumer wearables providing general health information, such as calorie counters or sleep monitors, will not be subject to regulation. This decision supports AI development in healthcare while ensuring patients do not rely on unverified data for medical decisions.

Read More »

J.P. Morgan’s Bold Move: Ditching Proxy Advisors for AI Voting

J.P. Morgan Asset & Wealth Management announced it will stop using third-party proxy advisory firms for U.S. proxy voting, opting for its AI-powered internal platform, Proxy IQ. This move reflects increased regulatory scrutiny and signals a shift toward more customized voting recommendations in the proxy advisory industry.

Read More »

AI Regulation Takes Center Stage in South Carolina

Amid national efforts toward deregulation, South Carolina is considering AI regulations in response to an MIT report highlighting AI’s potential to replace 11.7% of U.S. jobs. Local advocates emphasize the importance of state-level protections to ensure user safety and data privacy.

Read More »

EU AI Act Enforcement Intensifies Amid Trade War Tensions

As of January 8, 2026, the EU is strengthening enforcement of the EU AI Act by adopting a “super-regulator” model enforcing mandatory transparency on General-Purpose AI providers. This escalation is triggering geopolitical tensions with the US over regulatory compliance and trade concerns.

Read More »

China’s Regulatory Landscape for Meta’s Acquisition of Manus

On December 29, 2025, Meta announced its multi-billion-dollar acquisition of Manus, an AI start-up with Chinese origins that underwent significant offshore restructuring. The transaction raises complex regulatory issues in China, including merger control, national security reviews, and technology export controls.

Read More »